Enovis Starts Year Strong Despite Integration Impact and Comps
The company's recon sales grew in the high single digits on a pro forma basis as it integrates recent acquisitions. May 06, 2024
Zimmer Biomet on Track for MSD Growth Target
The company grew 3.2% in the 1Q24 but achieved its mid-single-digit growth target when adjusting for currency and selling days. May 03, 2024
Stryker Drives Q1 Growth in Face of Huge Comparisons
The company's orthopedic sales grew in the high-single-digits for 1Q24 against massive 2023 comparisons fueled by backlogged procedures. May 02, 2024
nView medical Announces First Adult Spine Surgery Using nView s1 Technology
The company's nView S1 imaging and navigation system completed its first adult spine surgery after more than 250 successful pediatric cases. Apr 29, 2024
Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study
The company completed a $11.5 million funding round to progress a clinical study of LDGraft, a bone graft substitute for spinal fusion. Apr 29, 2024
CONMED 1Q Performance Better Than Numbers Indicate
The company's orthopedic sales grew in the low single digits for 1Q24, but CONMED faced outsized comparisons and lingering supply issues. Apr 25, 2024
DePuy Synthes Sees Better Execution and Margins in First Quarter
The company grew in the mid-single-digits for 1Q24 but was aided by an unusually robust joint replacement market and one-time revenue items. Apr 18, 2024
Orthopedics’ Top Tier to Expand in 2024
According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023. Apr 10, 2024
Zimmer Biomet Takes on Challenging Surgeries with ROSA Shoulder
Zimmer Biomet's Nnamdi Njoku talks about the company's goal of supporting surgeons undertaking complex surgeries with ROSA Shoulder. Apr 02, 2024
U.S. Market Key to Unlocking Orthofix’s Trauma Business
While Orthofix's trauma business is growing slower than the market, it has an enormous opportunity in the U.S. Mar 18, 2024
